Abstract Aim: We aimed to evaluate the prognostic value of commissural morphology on immediate and short term outcome after Percutaneous balloon mitral valvuloplasty (PBMV). Methods: The study included 30 patients with symptomatic mitral stenosis (MS) scheduled for PBMV with these exclusion criteria: left atrial thrombi, High echocardiography score, Moderate to severe mitral regurgitation (MR), Atrial fibrillation (AF) or Calcification. After PBMV, they were randomized into 2 groups: Group I: 12 patients with only opened one commissure and group II: 18 patients with bilateral opened commissures. Results: Following PBMV, the mean mitral valve area (MVA) increased from 0.94 ± 0.19 to 1.86 ± 0.27 cm 2 in group I & from 0.91 ± 0.18 to 2.29 ± 0.33 cm 2 in group II (p = 0.001). The mean transmitral gradient (MG) decreased from 21.83 ± 4.1 to 8.08 ± 2.9 mmHg in group I and from 18.28 ± 5 to 5.2 ± 1.76 mmHg in group II (p = 0.003). The MVA was 1.85 ± 0.23 cm 2 in group I and 2.25 ± 0.31 cm 2 in group II (p = 0.001) and MG was 8.09 ± 2.90 mmHg in group I and 5.47 ± 1.79 mmHg in group II (p = 0.001). Three month follow-up: there was no patient developed AF, embolization or severe MR. Also, there was no mortality, redo, or surgery.
Introduction
Rheumatic heart disease (RHD) is an important contributor to cardiovascular disease in Egypt and many developing countries. About 25 percent of all patients with rheumatic heart disease have isolated mitral stenosis. 1 Rheumatic fever results in characteristic changes of the mitral valve with the diagnostic features being thickening at the leaflet edges, fusion of the commissures, and chordal shortening and fusion. Subsequent scarring leads to the characteristic valve deformity with obliteration of the normal leaflet architecture by fibrosis, neovascularization and increased collagen and tissue cellularity. Superimposed calcification results in further dysfunction. 2 Obstruction at the mitral valve level has important hemodynamic consequences, which account for many of the adverse clinical outcomes associated with this disease. Elevated left atrial pressure results in pulmonary artery hypertension with secondary effects on the pulmonary vasculature and right heart. In addition, left atrial enlargement and development of atrial fibrillation are associated with an increased risk of thrombus formation and systemic embolism. 3 Commissural fusion is recognized as the principal pathology underlying mitral stenosis, and commissural splitting underlies successful interventional treatment. Although the technique of surgical commissurotomy was first described as early as 1948, 4 percutaneous commissurotomy became a feasible option with the advent of balloon mitral valvuloplasty in 1984. 5 PBMV is now the treatment of choice for many patients with symptomatic mitral stenosis. Numerous large series have reported excellent short, medium, and long-term outcome [5] [6] [7] [8] with a low incidence of serious complications.9 Furthermore, randomized trials comparing balloon valvuloplasty with the surgical alternatives of open or closed commissurotomy have demonstrated equivalent outcome. 10, 11 However, patients treated using the percutaneous approach enjoy the advantages of reduced procedural morbidity and mortality and a short hospital stay. According to the last American College of Cardiology (ACC) and American Heart Association (AHA) guidelines focused update published in 2008, PBMV is considered as class I level of evidence A for the treatment of symptomatic patients (NYHA functional class II, III, or IV), with moderate or severe MS and valve morphology favorable for PBMV in the absence of left atrial thrombus or moderate to severe MR. 12 The outcomes of PBMV in different patients with MS are variable, in this study we aim to evaluate the prognostic value of commissural morphology on immediate and short term outcomes after the intervention.
Methods

Study population
The study population consisted of 30 patients with symptomatic mitral stenosis scheduled for percutaneous balloon mitral valvuloplasty admitted to the Department of cardiology, Alexandria Main University Hospital. Major criteria for exclusion were the presence of left atrial thrombi on transesophageal echocardiography (TEE), high Wilkin's echocardiographic score > 12, moderate to severe mitral regurgitation, calcification of commissures and previous mitral valve balloon valvuloplasty or surgery.
All patients were clinically reviewed to emphasize the history of rheumatic fever and the NYHA functional class. Standard 12 lead ECG was done to detect arrhythmia. Transthoracic echocardiography (TTE) using a commercial HP Sonos 4500 echocardiography machine was performed the day before and 24 to 48 h after the procedure then three months after PBMV for evaluation of the following: MVA as measured by planimetry; from 2D short axis images and Doppler pressure half time.
Mitral valve anatomy will be assessed according to Wilkin's criteria. 12 Mean transmitral diastolic gradient was assessed by continuous-wave Doppler. Mitral regurgitation will be semiquantitatively graded from 0 to 4 by color flow mapping. The degree of commissural pathology will be evaluated (in a parasternal short-axis view) as regards; calcification, number (unilateral or bilateral) and degree (partial or complete) of commissural closure. After PBMV (within first 48 h & then after 3 months) the commissures were assessed for the number and degree of commissural opening. Preprocedure TEE (within 24 h before procedure) was done to exclude left atrial thrombi and also to reassess Wilkin's score and interatrial septal wall thickness. At three months follow up: all patients were clinically reviewed for NYHA class, new onset atrial fibrillation, rehospitalization and need for redo or surgery.
2.2. Mitral balloon valvuloplasty using multitrack system technique: (Fig. 1) Dilation of the valvular orifice is performed on fasting patients under local anesthesia. Trans-septal puncture is the first and most crucial step of the procedure. This is done via the right femoral vein, monitoring arterial pressure by placing a pigtail catheter at the aortic root through the right femoral artery, usually through a 6 French sheath ( Fig. 1, a) . After accessing the femoral vein, 7 French Mullins dilator is passed over an exchange length wire of 0.025 or 0.032 inches diameter into the superior caval vein. The Brockenbrough needle is then passed to its tip into the Mullins dilator. With the index of the Brockenbrough needle pointing posteromedially, at 4 o' clock or 5 o' clock at the groin, the entire assembly is pulled down from the superior caval vein in anteroposterior view until it engages the atrial septum in the region of the fossa ovalis. Following this, the assembly of the Mullins dilator, with the needle just proximal to its tip, is manipulated in the lateral view, probing for the fossa. Once the assembly is fixed in the fossa, the floor is punctured by firm pressure on the dilator. As soon as the whole assembly enters the left atrium, atrial entry is confirmed by recording the waveform of the left atrial pressure, by oximetry, and by injection of contrast into the left atrium. After confirming entry to the left atrium, 100 units of heparin per kilogram of body weight are given in order to minimize the risk of thrombosis, and the gradient across the mitral valve is recorded by simultaneous recording of left atrial and left ventricular pressures. A balloon tipped Swan Ganz catheter is secured into the left ventricle through the Mullins sheath. A long stainless steel guide wire with a coiled floppy tip, 180 cm long, and of 0.025 inches in diameter, is then inserted into the left ventricle ( Fig. 1, b) . Following this, the site of septal puncture is dilated by passing a 14 French polyethylene dilator over the guidewire. Then two separate balloon catheters are positioned on a single guidewire. The first catheter, with only a distal guidewire lumen, is introduced into the vein and then advanced into the mitral orifice, then inflated alone ( Fig. 1, c) . Subsequently, a rapid exchange balloon catheter running on the same guidewire is inserted, and lined up with the first catheter so the two are positioned side-by-side, (Fig. 1, d) . Both balloons are then inflated simultaneously. The sum of the diameters of the two balloons chosen is around 90 to 100% of the measured value for the mitral valve annulus, (Fig. 1, e ).
The end point during staged dilation should be any of the following
Mitral valve area greater than 1 cm 2 /m 2 body surface area with split ends of the zone of apposition between the valvular leaflets. It is important to estimate the extent of splitting of the zone of apposition by using cross-sectional echocardiography in the short-axis view. Ends of the zone of apposition are sufficiently split to a point near the annulus; further dilation will cause significant mitral regurgitation. Similarly, if only one end is adequately split, further dilation requires extra care because of risk of excessive avulsion of that area to the mitral annulus, resulting in severe mitral regurgitation.
Mean gradient across mitral valve of less than 5 mmHg. Development of severe mitral regurgitation or an increase in severity of mitral regurgitation by one grade in patients with pre-existing mild to moderate mitral regurgitation.
Statistical analysis
All clinical, biological, echocardiographic and procedural data of all the patients were regularly recorded on standard forms and stored. Statistical analyses were performed with Microsoft Excel and SPSS software. Data were summarized using means and standard deviation (SD) for continuous variables, and frequency for categorical variables. Univariate analysis was performed either by student's t-test or Chi-square test, as appropriate. All P-values were significant if 6 0.05. 
Results
The studied patients were divided prospectively into 2 groups:
Group I: 12 patients with only 1 mitral commissure opened after PBMV.
Group II: 18 patients with both mitral commissures opened after PBMV.
The demographic characters of the patients
Group I included 12 patients, 11females (91.67%) and 1male (8.33%), their mean age was 29 ± 6.8 years ranging between years. On the other hand there were 2 males (11.1%) and 16 females (88.8%) in group II their mean age was 20.9 ± 3.2 years ranging between (17-29) years. There was no statistical significant differences between the 2 studied groups regarding sex but there was statistical significant difference between the 2 studied groups as regarding age. (P = 0.0001 * ). As seen in Table 1 .
Clinical presentation
All patients were complaining of dyspnea ranging from NYHA functional class (I-IV) with no statistical significant difference between the 2 studied groups with most of them were in NYHA functional class III (66.6%). No one complained of orthopnea or PND. There was no history of previous embolization or previous commissurotomy.
Echocardiography
Baseline characteristics of group 1 and group 2 are summarized in Tables 2 and 4 respectively. MVA ranged between (0.6-1.3) cm 2 with a mean of 0.94 + 0.2 cm 2 in group I and between (0.7-1.4 cm 2 ) with a mean of 0.9 + 0.18 cm 2 in group II, with no statistically significant difference between the two groups as seen in Table 6 .
Mitral valve score according to Wilkin's criteria ranged between (6-10) with a mean of 8.2 + 1.2 in group I and ranged between (6-12) with a mean of 8.1 + 1.4 in group II with most of the patients having flexible valve and moderate subvalvular disease. In group I the mean diastolic gradient ranged between (16-28) mmHg with a mean of 21.83 ± 4.13 mmHg, and ranged between (11-26) mmHg in group II with a mean of 18.28 ± 5.00 mmHg, the mean diastolic gradient of MV was higher in group 1 than in group 2 with statistically significant difference (p = 0.02) as seen in Table 7 . As regards MR, in group I there were 9 patients who had no MR and 3 patients had mild degree of MR on the other hand in group II there were 11 patients who had no MR, 3 patients had trivial degree of MR and 4 patients had mild degree of MR, with no statistical significant difference between the two studied groups. As seen in Table 8 .
PAP ranged between (25-55) mmHg with mean of 37 ± 8.8 mmHg in group I & between (30-90) mmHg with a mean of 52.4 ± 21 mmHg in group II. 11 patients had mild pulmonary hypertension (PHTN) and only one patient had moderate PHTN in group I, in comparison with group II, there were 9 patients who had mild PHTN,7 patients had moderate PHTN and & 2 patients had severe PHTN with no statistical significant difference between the two studied groups. In all our patients no one had LAA thrombi. LA diameter ranged between (43-50) mm & (42-66) mm in groups I and II with a mean of 46.5 ± 2.4 mm &49.4 ± 7.5 mm respectively with no statistical significant difference between the two studied groups.
Months follow up
The impact of commissural splitting was reassessed after 3 months in all patients. Follow-up was complete in all patients. During follow up no recorded cases of death, hospital admission, redo, or surgery or infective endocarditis & most of them were in NYHA functional class (I-II).
The MVA ranged between (1.6-2.1) with mean 1.8 cm 2 in group I and ranged between (1.8-3.1) with mean 2.2 cm 2 in group II with highly statistical significant difference between the two studied groups (p = 0.001) and there was no difference in MVA between immediate follow up and three months follow up. The mean transmitral gradient ranged between (3-12) with mean 8.09 mmHg in group I and ranged between (3-9) with mean 5.47 mmHg in group II with highly statistical significant difference between the 2 studied groups (p = 0.001) and there was no difference in transmitral gradient between immediate follow up and three months follow up.
As regards the degree of MR, opening of 2 commissures in group II had more newly developed MR but with no statistical significant difference between the two groups and there was no difference in the degree of mitral regurgitation between immediate follow up and three months follow up.
The immediate and three months follow up of group 1 and group 2 are summarized in Tables 3 and 5 respectively. A case example of female patient of 21 years old; belonging to group 2 is summarized in (Fig. 2) .
Discussion
Pioneering clinical and pathology studies have shown that commissural opening is the main mechanism by which MVA increases after balloon valvuloplasty (percutaneous commissurotomy). 13 Commissural calcification, an important predictor of unsuccessful commissurotomy and failure of commissural opening is associated with a poor midterm event free survival and a high incidence of mitral valve replacement. 13, 14 However, the relationship between the degree of commissural opening and post-procedural MVA has not been extensively evaluated. No  30  52  8  1.4  2  2  2  0  6  21  42  2closed  Trivial  30  42  9  0.9  2  2  3  1  5  14  50  2closed  Mild  60  50  10  0.7  2  2  3  0  7  15  43  1closed + 1 partial  Moderate  70  45  11  1  2  3  2  0  7  16  45  2closed  Mild  30  45  12  0.8  3  4  3  0  10  26  66  2closed  Moderate  70  66  13  0.7  3  2  3  1  9  19  43  2closed  Mild  40  43  14  0.5  2  2  4  1  9  21  43  2closed  Mild  90  43  15  0.9  3  2  2  0  7  24  52  1closed + 1 partial  No  30  52  16  1  2  2  3  1  8  11  42  2closed  Trivial  30  42  17  0.9  2  2  3  0  7  21  50  2closed  Mild  60  50  18  0.5  2  3  2  0  7  14  45  1closed + 1 partial  Moderate  70  45 In our study, we demonstrated that MVA progressively increased with the number and the extent of commissural opening. Our results confirmed the impression that older patients had less chance to open more commissures. In agreement with the present study, David et al., 15 studied the impact of degree of commissural opening after percutaneous mitral commissurotomy on long-term outcome, where patients were divided into 3 groups: both commissures only partially opened or not split, one commissure completely split and both commissures completely split. Patients in the first group were older.
In concordance to our results, David et al., 15 reported a significant difference as regards the post-procedure mean transmitral gradient and MVA in patients with bilateral commissural opening. Thus, mean transmitral gradient decreased and MVA increased parallel to the degree of commissural opening. D Fatkin et al. 16 also reported similar data. They studied 30 consecutive patients, on the basis of the two-dimensional echocardiographic commissural morphology: the extent of fusion, fibrosis or calcification of each commissure. Splitting of one or both commissures occurred in 24 patients (80%) and was associated with a significantly greater mean increase in valve area (85%) than if neither commissure was split (13%). They found that, a good outcome from valvotomy (defined as valve area > 1.5 cm 2 and increase in valve area > 25%) was achieved in 96% of those in whom one or both commissures split, but in none of the patients in whom neither commissure split. Consequently, the splitting of one or both commissures was associated with a good outcome in 23 (89%) of 26 patients, on the other hand when both commissures remained closed the outcome was not good in any patient.
As regards post-procedural mitral regurgitation, the current study revealed that opening of 2 commissures in group II resulted in more patients developing new mild mitral regurgitation than opening of one commissure in group I with no significant impact on outcome. In agreement with our results, Duk-Hyun Kang et al. 17 studied 302 consecutive patients in a prospective, randomized trial comparing two procedures, patients who underwent percutaneous mitral valvuloplasty (PMV) using Inoue or double-balloon technique, found that both the Inoue and double-balloon techniques obtained a similar incidence of commissural mitral regurgitation. The annual echocardiographic follow-up data suggested that the natural course of most commissural mitral regurgitation was benign during follow-up and that the rate of decrease in MVA after PMV was significantly slower in patients with commissural mitral regurgitation compared with those without commissural regurgitation. Previous studies also reported that the mechanisms of development of MR after PMV were different for mild and severe MR. Mild MR was produced by complete commissurotomy, but severe MR was produced by leaflet tears or chordal rupture. 18, 19 The mechanism by which commissural regurgitation maintains initial gain in MVA is unclear. The decrease in MVA after PMV may be related to the fusion of split commissure and recoil of the stretch component. Complete commissurotomy and commissural regurgitation might prevent immediate recoil and late fusion by preventing apposition of split commissures.
While PBMV is a safe and effective procedure for the treatment of rheumatic MS, development of atrial fibrillation (AF), redo PBMV, or the need of surgical intervention is not uncommon during long term follow up. In our study no one had early onset (3 months) of AF, redo or surgery. Atrial fibrillation is a common late complication of mitral stenosis. 20 It is already reported that AF is an important predictor for unfavorable clinical outcome (death, reintervention or mitral valve replacement) and restenosis after PBMV. Chronic AF was the only factor with predictive value for these events before intervention. The duration of chronic AF was also important for its predictive value if chronic AF at the time of PBMV had been present for more than one year, the risk of an event or restenosis during follow-up increased seven fold. 21 Independent predictors for the need to undergo surgery after PMV include the presence of significant MR after PBMV, the echo score before PBMV, the residual mitral gradient after PBMV, and the NYHA score at first follow-up. This partially agrees with the results of David et al. 15 which showed the impact of commissural splitting on late functional results. Mean follow-up duration was 55 ± 28 months. During follow-up, 0.02% cardiovascular deaths were observed, and 11% underwent repeat PMC or mitral valve surgery. The difference of result of follow up between our study and David et al. 15 may be explained by short period of follow up and smaller number of patients in our study. The impact of commissural morphology on clinical outcome in patients
Conclusion
Commissural splitting is the dominant mechanism by which mitral valve area is increased in PBMV, and it can be predicted by echocardiographic assessment of commissural morphology. Mitral valve commissural morphology should be evaluated properly when selecting patients before percutaneous balloon mitral valvuloplasty. The present study demonstrates that commissural opening degree and mitral valve area are closely related. The degree of commissural opening provides important prognostic information, and complete commissural opening is associated with better results. Degree of commissural opening should be systematically evaluated during and after percutaneous balloon mitral valvuloplasty and can be considered as a complementary measure of the procedural success.
Study limitations
These results are to be interpreted in consideration of the small number of patients and short duration of follow up.
